SCHEMBL21983450

SCHEMBL21983450

Cc1ccc2cc(C)n(CF)c2c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.39
▸ CYP2A6 P11509 3/20 0.39
▸ MAPT P10636 2/20 0.38
▸ RXFP1 Q9HBX9 1/20 0.38
▸ CCR9 P51686 1/20 0.38
▸ HTR2A P28223 2/20 0.37
▸ HTR2C P28335 2/20 0.37
▸ MEN1 O00255 4/20 0.36
▸ KMT2A Q03164 4/20 0.36
▸ USP2 O75604 1/20 0.36
▸ ESR1 P03372 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CYP19A1 P11511 3/20 0.35
▸ TDP1 Q9NUW8 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ TP53 P04637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21335596 0.82 MAPT (0.43) CYP1A2CYP2A6MAPTRXFP1CCR9
SCHEMBL21983449 0.80 HTR2A (0.41) CYP1A2CYP2A6MAPTRXFP1CCR9
SCHEMBL13044181 0.79 MAPT (0.50) CYP1A2CYP2A6MAPTRXFP1CCR9
SCHEMBL21983721 0.78 HSD17B10 (0.37) CYP1A2CYP2A6MAPTRXFP1CCR9
SCHEMBL15241815 0.78 MAPT (0.36) MAPTRXFP1MEN1KMT2ATDP1
SCHEMBL27990378 0.75 CCR9 (0.49) MAPTCCR9CYP2C9KDM4EKMO
SCHEMBL21983719 0.75 KMT2A (0.40) CYP1A2MAPTRXFP1HTR2AHTR2C
SCHEMBL21983448 0.74 CCR9 (0.37) CYP1A2MAPTCCR9MEN1KMT2A
SCHEMBL10987529 0.74 KDM4E (0.42) CYP1A2MAPTRXFP1HTR2AHTR2C
SCHEMBL5986735 0.71 MAPT (0.52) CYP1A2CYP2A6MAPTRXFP1HTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3647311-B1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF BEIJING TIDE PHARMACEUTICAL CO LTD (CN) 2023-11-01 — — EP disclosed
EP-3932404-A1 METHOD FOR TREATING FATTY LIVER DISEASE AND/OR STEATOHEPATITIS Beijing Tide Pharmaceutical Co., Ltd. (CN) 2022-01-05 — — EP disclosed
EP-3647311-A1 RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD AND USE THEREOF Beijing Tide Pharmaceutical Co., Ltd. (CN) 2020-05-06 — — EP disclosed
Send feedback